Edofoam ER 200 Tablet containing Etodolac is used for the management of pain and inflammatory conditions. It helps reduce pain, inflammation, and discomfort while supporting improved physical mobility and daily functioning.
Etodolac works as a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and swelling, helping provide effective symptom relief.
The extended-release tablet is widely prescribed in orthopedic, rheumatology, and general medicine practice for musculoskeletal pain, joint disorders, and inflammatory conditions, leading to consistent prescription demand.
With increasing prevalence of pain-related disorders and growing demand for effective anti-inflammatory therapies, this product offers strong business potential for retailers and distributors. Its established therapeutic profile, prolonged-release formulation, and steady market demand make it a reliable product for growth in the pain management segment.